KEVIN GAREY to Microbial Viability
This is a "connection" page, showing publications KEVIN GAREY has written about Microbial Viability.
Connection Strength
0.210
-
Evaluation of a shoe sole UVC device to reduce pathogen colonization on floors, surfaces and patients. J Hosp Infect. 2018 Jan; 98(1):96-101.
Score: 0.145
-
Ridinilazole: a novel therapy for Clostridium difficile infection. Int J Antimicrob Agents. 2016 Aug; 48(2):137-43.
Score: 0.033
-
Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection. J Antimicrob Chemother. 2016 May; 71(5):1245-51.
Score: 0.032